OmpT outer membrane proteases of enterohemorrhagic and enteropathogenic Escherichia coli contribute differently to the degradation of human LL-37

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 483-492

  Thomassin, Jenny Lee ^a   Brannon, John R ^a   Gibbs, Bernard F ^a   Gruenheid, Samantha ^a   Le Moual, Hervé ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; OMPT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; GENE DELETION; GENE EXPRESSION; GENE FUSION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ANTIMICROBIAL CATIONIC PEPTIDES; DRUG RESISTANCE, BACTERIAL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICROBIAL SENSITIVITY TESTS; PROMOTER REGIONS, GENETIC; SERINE ENDOPEPTIDASES;

EID: 84857172277     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05674-11     Document Type: Article

References (43)

1. Bevins CL, Salzman NH. 2011. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat. Rev. Microbiol. 9:356 -368.
2. Burton MF, Steel PG. 2009. The chemistry and biology of LL-37. Nat. Prod. Rep. 26:1572-1584.
3. Campos MA, et al. 2004. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 72:7107-7114.
4. Darveau RP, et al. 1992. Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J. Clin. Invest. 90:447-455.
5. Dekker N, Cox RC, Kramer RA, Egmond MR. 2001. Substrate specificity of the integral membrane protease OmpT determined by spatially addressed peptide libraries. Biochemistry 40:1694 -1701.
6. Donnenberg MS, Kaper JB. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect. Immun. 59:4310-4317.
7. Edwards RA, Keller LH, Schifferli DM. 1998. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207: 149-157.
8. Eren E, Murphy M, Goguen J, van den Berg B. 2010. An active site water network in the plasminogen activator Pla from Yersinia pestis. Structure 18:809-818.
9. Foschiatti M, Cescutti P, Tossi A, Rizzo R. 2009. Inhibition of cathelicidin activity by bacterial exopolysaccharides. Mol. Microbiol. 72:1137-1146.
10. Galvan EM, Lasaro MA, Schifferli DM. 2008. Capsular antigen fraction 1 and Pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin. Infect. Immun. 76:1456 -1464.
11. Guina T, Yi EC, Wang H, Hackett M, Miller SI. 2000. A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to alpha-helical antimicrobial peptides. J. Bacteriol. 182:4077-4086.
12. Haiko J, Laakkonen L, Juuti K, Kalkkinen N, Korhonen TK. 2010. The omptins of Yersinia pestis and Salmonella enterica cleave the reactive center loop of plasminogen activator inhibitor 1. J. Bacteriol. 192:4553-4561.
13. Haiko J, Suomalainen M, Ojala T, Lahteenmaki K, Korhonen TK. 2009. Breaking barriers-attack on innate immune defences by omptin surface proteases of enterobacterial pathogens. Innate Immun. 15:67-80.
14. Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF. 2002. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 70:953-963.
15. Hase K, et al. 2003. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 125:1613-1625.
16. Hritonenko V, Stathopoulos C. 2007. Omptin proteins: an expanding family of outer membrane proteases in Gram-negative Enterobacteriaceae. Mol. Membr. Biol. 24:395-406.
17. Iimura M, et al. 2005. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol. 174:4901-4907.
18. Jenssen H, Hamill P, Hancock RE. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511.
19. Kai-Larsen Y, et al. 2010. Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog. 6:e1001010.
20. Kerr FK, et al. 2005. Elucidation of the substrate specificity of the C1s protease of the classical complement pathway. J. Biol. Chem. 280:39510-39514.
21. Kukkonen M, Korhonen TK. 2004. The omptin family of enterobacterial surface proteases/adhesins: from housekeeping in Escherichia coli to systemic spread of Yersinia pestis. Int. J. Med. Microbiol. 294:7-14.
22. Kukkonen M, et al. 2001. Protein regions important for plasminogen activation and inactivation of α_2-antiplasmin in the surface protease Pla of Yersinia pestis. Mol. Microbiol. 40:1097-1111.
23. Lahteenmaki K, Kyllonen P, Partanen L, Korhonen TK. 2005. Antiprotease inactivation by Salmonella enterica released from infected macrophages. Cell. Microbiol. 7:529 -538.
24. Le Sage V, et al. 2009. An outer membrane protease of the omptin family prevents activation of the Citrobacter rodentium PhoPQ two-component system by antimicrobial peptides. Mol. Microbiol. 74:98 -111.
25. Levine MM, et al. 1978. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet i:1119 -1122.
26. -ΔΔCT method. Methods 25:402-408.
27. Mellies JL, Barron AM, Carmona AM. 2007. Enteropathogenic and enterohemorrhagic Escherichia coli virulence gene regulation. Infect. Immun. 75:4199-4210.
28. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
29. Nelson DL, Kennedy EP. 1971. Magnesium transport in Escherichia coli. Inhibition by cobaltous ion. J. Biol. Chem. 246:3042-3049.
30. Nijnik A, Hancock RE. 2009. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr. Opin. Hematol. 16:41-47.
31. Parra-Lopez C, Baer MT, Groisman EA. 1993. Molecular genetic analysis of a locus required for resistance to antimicrobial peptides in Salmonella typhimurium. EMBO J. 12:4053-4062.
32. Peschel A, Sahl HG. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529 -536.
33. Ramu P, et al. 2007. The surface protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5. FEBS Lett. 581:1716 -1720.
34. Riley LW, et al. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685.
35. Roland K, Curtiss R III, Sizemore D. 1999. Construction and evaluation of a Δcya Δcrp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis. 43:429-441.
36. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
37. Simon R, Priefer U, Pühler A. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gramnegative bacteria. Biotechnology (NY) 1:784 -791.
38. Sodeinde OA, et al. 1992. A surface protease and the invasive character of plague. Science 258:1004 -1007.
39. Stumpe S, Schmid R, Stephens DL, Georgiou G, Bakker EP. 1998. Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J. Bacteriol. 180:4002-4006.
40. Sugimura K, Nishihara T. 1988. Purification, characterization, and primary structure of Escherichia coli protease VII with specificity for paired basic residues: identity of protease VII and OmpT. J. Bacteriol. 170:5625-5632.
41. Vandeputte-Rutten L, et al. 2001. Crystal structure of the outer membrane protease OmpT from Escherichia coli suggests a novel catalytic site. EMBO J. 20:5033-5039.
42. Wiegand I, Hilpert K, Hancock RE. 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3:163-175.
43. Yip CK, et al. 2005. Structural characterization of the molecular platform for type III secretion system assembly. Nature 435:702-707.